PLSM· Health Care› Medical Devices

Pulsenmore Ltd.

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. More about the company

$1.77

-1.78% today

$11.5M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is PLSM early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2026-01-21 → 2026-10-22

S? 39w

2026-01-212026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 39w current

Total tracked: 39 weeks across 1 stage run.

PLSM among Medical Devices137th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…137	PLSMPulsenmore Ltd.	—	—	−27.5%

vs 52W High

—

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 39

1w13w26w

Week 39, mature

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

—

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.18x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-27.5%

-48.4%

-51.6%

YTD

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S—

Wk 39 · Vol 0.18x

2026-10-21S—

Wk 38 · Vol 0.17x

2026-10-20S—

Wk 38 · Vol 0.74x

2026-10-19S—

Wk 38 · Vol 0.25x

2026-10-16S—

Wk 38 · Vol 0.39x

2026-10-15S—

Wk 38 · Vol 0.46x

2026-10-14S—

Wk 37 · Vol 0.58x

2026-10-13S—

Wk 37 · Vol 0.56x

2026-10-12S—

Wk 37 · Vol 0.25x

2026-10-09S—

Wk 37 · Vol 0.23x

2026-10-08S—

Wk 37 · Vol 0.48x

2026-10-07S—

Wk 36 · Vol 1.07x

Moving averages & range

50 DMA

$2.37

200 DMA

—

52W High

—

52W Low

—

5D Low

$1.76

Resistance levels (recent highs)

20d High

$2.41

60d High

$3.65

120d High

$6.59

250d High

—

Next resistance

+36.2%

to 20d High

ROE

-45.2%

Profit margin -65.9%

Dividend Yield

0.00%

P/B —

Pulsenmore: quick answers

Which sector and industry is Pulsenmore in?

Pulsenmore is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe. The company was incorporated in 2014 and is based in Omer, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.